Konstanze Spieth

872 total citations
24 papers, 587 citations indexed

About

Konstanze Spieth is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Konstanze Spieth has authored 24 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Dermatology and 8 papers in Molecular Biology. Recurrent topics in Konstanze Spieth's work include Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (5 papers) and Autoimmune and Inflammatory Disorders (4 papers). Konstanze Spieth is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (5 papers) and Autoimmune and Inflammatory Disorders (4 papers). Konstanze Spieth collaborates with scholars based in Germany, Switzerland and United Kingdom. Konstanze Spieth's co-authors include Roland Kaufmann, Jens Gille, Dirk Schadendorf, Wolfgang Tilgen, R Linse, Axel Hauschild, Thomas Vogt, Maurizio Podda, Manfred Wolter and Reinhard Dummer and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Konstanze Spieth

23 papers receiving 568 citations

Peers

Konstanze Spieth
K. Acland United Kingdom
Mirjana Urosevic‐Maiwald Switzerland
Günther Sebastian Germany
Lutz Kretschmer Germany
Christoph U. Brand Switzerland
Mikio Ohtsuka Japan
Giulia Veronesi Italy
Jochen T. Schaefer United States
Susanna Rossari Italy
Melanie Warycha United States
K. Acland United Kingdom
Konstanze Spieth
Citations per year, relative to Konstanze Spieth Konstanze Spieth (= 1×) peers K. Acland

Countries citing papers authored by Konstanze Spieth

Since Specialization
Citations

This map shows the geographic impact of Konstanze Spieth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstanze Spieth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstanze Spieth more than expected).

Fields of papers citing papers by Konstanze Spieth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstanze Spieth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstanze Spieth. The network helps show where Konstanze Spieth may publish in the future.

Co-authorship network of co-authors of Konstanze Spieth

This figure shows the co-authorship network connecting the top 25 collaborators of Konstanze Spieth. A scholar is included among the top collaborators of Konstanze Spieth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstanze Spieth. Konstanze Spieth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egberts, Friederike, Matthias Volkenandt, Monika Schmid-Wendtner, et al.. (2011). Health-related Quality of Life Before and During Adjuvant Interferon-α Treatment for Patients With Malignant Melanoma (DeCOG-Trial). Journal of Immunotherapy. 34(4). 403–408. 28 indexed citations
2.
Hassel, J.C., Antje Sucker, Lutz Edler, et al.. (2010). MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. British Journal of Cancer. 103(6). 820–826. 38 indexed citations
3.
Hauschild, Axel, Michael Weichenthal, Knuth Rass, et al.. (2010). Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial. Journal of Clinical Oncology. 28(5). 841–846. 50 indexed citations
4.
Egberts, Friederike, Matthias Volkenandt, Wolfgang Tilgen, et al.. (2009). Depressive Mood Changes and Psychiatric Symptoms During 12-month Low-dose Interferon-α Treatment in Patients With Malignant Melanoma. Journal of Immunotherapy. 33(1). 106–114. 29 indexed citations
5.
Spieth, Konstanze, Roland Kaufmann, Reinhard Dummer, et al.. (2008). Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). Annals of Oncology. 19(4). 801–806. 23 indexed citations
6.
Valesky, Eva, et al.. (2007). Postoperatives Pyoderma gangraenosum Cullen. Der Unfallchirurg. 110(11). 973–976. 4 indexed citations
7.
Meißner, Markus, Konstanze Spieth, Manfred Wolter, et al.. (2007). Kutane Botryomykose. Der Hautarzt. 58(11). 966–969. 7 indexed citations
8.
9.
Spieth, Konstanze, et al.. (2006). Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa. The Lancet Oncology. 7(12). 1036–1037. 25 indexed citations
10.
Gille, Jens, Konstanze Spieth, & Roland Kaufmann. (2005). Metronomic low‐dose chemotherapy as antiangiogenic therapeutic strategy for cancer. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 3(1). 26–32. 29 indexed citations
11.
Meißner, Markus, Konstanze Spieth, Thomas Löffler, et al.. (2005). Rötlicher lobulärer Tumor des Zungenrückens. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 3(12). 1007–1008. 1 indexed citations
12.
Spieth, Konstanze, Roland Kaufmann, & Jens Gille. (2003). Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study. Cancer Chemotherapy and Pharmacology. 52(5). 377–382. 49 indexed citations
13.
Spieth, Konstanze, M. Grundmann-Kollmann, U Runne, et al.. (2002). Mycosis-fungoides-Type Cutaneous T Cell Lymphoma of the Hands and Soles: A Variant Causing Delay in Diagnosis and Adequate Treatment of Patients with Palmoplantar Eczema. Dermatology. 205(3). 239–244. 23 indexed citations
14.
Gille, Jens, Konstanze Spieth, & Roland Kaufmann. (2002). Sweet's syndrome as initial presentation of diffuse large B-cell lymphoma. Journal of the American Academy of Dermatology. 46(2). S11–S13. 13 indexed citations
15.
Gille, Jens, Konstanze Spieth, & Roland Kaufmann. (2002). Sweet's syndrome as initial presentation of diffuse large B-cell lymphoma. Journal of the American Academy of Dermatology. 46(2). S11–S13. 3 indexed citations
16.
Gille, Jochen, Konstanze Spieth, & Roland Kaufmann. (2000). Kutane Varianten der Langerhans-Zell-Histiozytose im frühen Kindesalter. Der Hautarzt. 51(12). 939–944.
17.
Grundmann-Kollmann, M., Falk Ochsendorf, Thomas M. Zollner, et al.. (2000). PUVA-cream photochemotherapy for the treatment of localized scleroderma. Journal of the American Academy of Dermatology. 43(4). 675–678. 45 indexed citations
18.
Spieth, Konstanze, Jens Gille, & Roland Kaufmann. (2000). Intralesional Methotrexate as Effective Treatment in Solitary Giant Keratoacanthoma of the Lower Lip. Dermatology. 200(4). 317–319. 30 indexed citations
19.
Podda, Maurizio, Konstanze Spieth, & Roland Kaufmann. (2000). Er:YAG Laser-Assisted Hair Transplantation in Cicatricial Alopecia. Dermatologic Surgery. 26(11). 1010–1014. 15 indexed citations
20.
Spieth, Konstanze. (1999). Therapeutic Efficacy of Interferon Alfa-2a and 13-cis-Retinoic Acid in Recurrent Angiosarcoma of the Head. Archives of Dermatology. 135(9). 1035–1035. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Acland Breakdown of academic impact, for papers by Mirjana Urosevic‐Maiwald Breakdown of academic impact, for papers by Günther Sebastian Breakdown of academic impact, for papers by Lutz Kretschmer Breakdown of academic impact, for papers by Christoph U. Brand Breakdown of academic impact, for papers by Mikio Ohtsuka Breakdown of academic impact, for papers by Giulia Veronesi Breakdown of academic impact, for papers by Jochen T. Schaefer Breakdown of academic impact, for papers by Susanna Rossari Breakdown of academic impact, for papers by Melanie Warycha
Rankless by CCL
2026